W

Walleye Capital portfolio

Walleye Capital has 3 portfolio companies on record at Recent Funding. Its most recent investment on record is Agomab Therapeutics's $95.45M Series B+ round in October 2023, alongside Redmile Group, Pontifax, Pfizer and 6 others. By category, its portfolio leans toward Health and bio (2) and Fintech (1). It has co-invested with Canaan Partners, Fidelity and Asabys Partners.

What Walleye Capital invests in

• Health and bio · 2 · 67%
• Fintech · 1 · 33%
• Developer tools and cloud · 1 · 33%
• Sales and marketing · 1 · 33%
• Real estate and construction · 1 · 33%

Walleye Capital recent investments

Company	Round	Date	Alongside
AAgomab Therapeutics	Series B+ · $95.45M	Oct 11, 2023	Redmile Group, Pontifax, Pfizer +6
CClear Street	Series B+ · $165M	May 14, 2022	Validus Growth Investors, Prysm Capital (lead), NextGen Venture Partners +6
CCloudbeds	Series B+ · $150M	Nov 3, 2021	Viking Global Investors, SoftBank Vision Fund (lead), PeakSpan Capital +2

How Walleye Capital invests

Share is of the 3 rounds on Recent Funding that name Walleye Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Walleye Capital portfolio companies

• AAgomab Therapeutics$95.45MSeries B+ · Oct 2023
• CClear Street$165MSeries B+ · May 2022
• CCloudbeds$150MSeries B+ · Nov 2021

Company	Round with Walleye Capital	Total raised	Latest raise
AAgomab Therapeutics Health and bio	Oct 11, 2023 Series B+ · $95.45M	$193.45M	Oct 11, 2023 Series B+
CClear Street Fintech	May 14, 2022 Series B+ · $165M	$435M	Apr 11, 2023 Series B+
CCloudbeds Sales and marketing	Nov 3, 2021 Series B+ · $150M	$244M	Nov 3, 2021 Series B+

Most frequent co-investors

• CCanaan Partners1 shared round · last Oct 11, 2023
• FFidelity1 shared round · last Oct 11, 2023
• AAsabys Partners1 shared round · last Oct 11, 2023
• EEQT Life Sciences1 shared round · last Oct 11, 2023
• CCormorant Asset Management1 shared round · last Oct 11, 2023
• RRedmile Group1 shared round · last Oct 11, 2023
• PPontifax1 shared round · last Oct 11, 2023
• PPfizer1 shared round · last Oct 11, 2023
• DDawn Biopharma1 shared round · last Oct 11, 2023
• PPrysm Capital1 shared round · last May 14, 2022
• MMoses Lo1 shared round · last May 14, 2022
• VValidus Growth Investors1 shared round · last May 14, 2022

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• IInnovestor3 companies · 3 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• GGoHub Ventures3 companies · 2 deals in 12 mo
• HHealthier Capital3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Walleye Capital, which is a subset of its real portfolio. API: /api/v1/investors/walleye-capital (get a free API key). More: the most active VC firms and new venture capital funds.